Dale Terasaki, MD, MPH
Assistant Professor, Medicine-Internal Medicine

Photo
Medical School:
  • MD, University of Washington School of Medicine (2015)
Graduate School :
  • MPH, University of Washington (2013)
Undergraduate School:
  • BS, University of Washington (WA) (2009)
Internship:
  • University of Colorado (University Hospital) Program (2016)
Residency:
  • University of Colorado (University Hospital) Program, Internal Medicine (2018)
Fellowships:
  • University of Colorado (University Hospital) Program, Addiction Medicine (2019)
Languages: English, Spanish
Department: Medicine-Internal Medicine

Professional Titles

  • Attending physician, Inpatient addiction consult service
  • Faculty member, Addiction medicine fellowship
  • Faculty member, Addiction psychiatry fellowship

Recognition & Awards

  • Colorado Health Service Corps, Colorado Department of Public Health & Environment (2020)
    3-year service commitment to substance use disorder treatment in high need area
  • 5280 Top Doc for Addiction Medicine, 5280 Magazine (2020)

Research Interests

My research interests are focused on novel interventions for hospitalized patients with substance use disorders.

Publications

  • Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 Mar 4;. doi: 10.1016/j.ajem.2022.02.060. [Epub ahead of print] PubMed PMID: 35279327.
  • Terasaki D, Shaffie R, Loh R (2022). Characteristics of hospitalized patients whose substance use increased amid the impacts of COVID-19. The Hospitalist. Online publication. March 3, 2022. Available at: https://www.the-hospitalist.org/
  • Mortaji P, Terasaki D, Moo-Young J. Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. J Gen Intern Med. 2021 Aug;36(8):2448-2451. PubMed PMID: 33782885
  • Terasaki D (2021). Methadone disposition on a Friday. SGIM Forum 44 (8): 8, 12.
  • Terasaki D & Klie K. Tramadol withdrawal in setting of buprenorphine induction, a case report. Journal of Addiction Medicine. May/Jun 2020;14(3):264-266.
  • Terasaki, D. (2019) Clinical Harm Reduction for Addiction: A Strategy Internists Can (And Do) Embrace. SGIM Forum 42 (9): 5, 9.
  • Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 Oct;39(10):1023-1029. PubMed PMID: 31348544
View All (7 Total) View Less

Professional Memberships

  • American Society of Addiction Medicine, Member

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • Denver Health Medical Center

Specialty Information

Specialties
  • Internal Medicine, Board Certification (2018)
  • Addiction Medicine, Board Certification (2019)
Public Speaking
Yes
Addiction medicine, Harm reduction, Built environment

General Information

Medical Schools:
  • MD, University of Washington School of Medicine (2015)
Graduate Schools:
  • MPH, University of Washington (2013)
Undergraduate Schools:
  • BS, University of Washington (WA) (2009)
Internships:
  • University of Colorado (University Hospital) Program (2016)
Residency Programs:
  • University of Colorado (University Hospital) Program, Internal Medicine (2018)
Fellowships:
  • University of Colorado (University Hospital) Program, Addiction Medicine (2019)
Languages: English, Spanish
Department: Medicine-Internal Medicine
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;